Why a $1 vitamin sells for $8 — and who keeps the difference

A vitamin that costs about $1 to manufacture sells for roughly $8 on the shelf.

That 8x doesn't go to the factory. And it doesn't go to the clinic, retailer or brand that actually creates the demand. It's captured in the middle — by the layers that sit between the manufacturer and the final customer.

Most importers never see it. The number they watch — the supplier's FOB price — still looks "competitive." So they negotiate a few points off that price, feel good about the deal, and never ask the more important question: what is this product actually costing me by the time it reaches the shelf?

The blind spot

For two decades, importing well meant buying cheap: optimize the factory price, choose a freight forwarder by cost, reuse last year's Incoterm. That playbook worked in a stable world.

It doesn't anymore. The US–China tariff war, freight inflation and a fragmented geopolitical order have rewritten the rules. The share of the final price that comes from tariffs, freight, demurrage, regulatory packaging, working capital and currency risk now outweighs the factory price in many categories.

When that happens, the supplier's quote is the wrong thing to optimize. The chain is.

What we actually did

A company in the supplement space asked us to negotiate a better deal with their distributor. We didn't. Instead, we redesigned the chain:

• Sourced the manufacturer directly in China.

• Built a private label with a formula tuned to their market.

• Removed the intermediaries that were quietly owning the margin.

The result wasn't "cheaper importing." It was a different business model — one where the 8x is captured by the people who drive the demand, not by the layers in between.

That's the difference between negotiating a discount and re-architecting an operation.

The three questions that decide your margin

We work from a single framework — 3C: Country, Cost, Capital. It is the integrated answer to the three questions that determine whether an international operation still has margin twelve months from now:

• Country — Where should you source, under today's tariff regime? Concentration in a single jurisdiction is a risk; "China+1" is an access strategy, not a trend.

• Cost — How is the full chain structured, from sourcing to the shelf? The hidden markup lives between the links — and a freight term chosen out of habit can cost more than the price you negotiated.

• Capital — What does the product really cost, given your financial structure? The same product does not cost the same to two importers. Cost of money, a ~90-day working-capital cycle and leverage define your real margin.

Optimize one and ignore the other two, and you do what the market has always done: lose money you can't see.

The takeaway

Importing well stopped being about buying cheap. It became about architecting the whole chain under a new set of rules.

If your landed cost keeps climbing and you can't fully pass it on, the gap is almost always hiding in the chain — not in the supplier's price. The first step is simply to look at the whole thing at once.

Snell Consult LLC is an international trade intelligence advisory operating across Brazil, the US and China, with teams in Miami, Belo Horizonte and Hong Kong. For a read on where margin is hiding in your operation, a 30-minute discovery call is the place to start — Gabriel@snelllc.com.